Neo-self antigens and the expansion of B-1 cells: Lessons from atherosclerosis-prone mice

Current Topics in Microbiology and Immunology

Volumn 252, Issue , 2000, Pages 189-200

  Silverman, G J ^a   Shaw, P X ^a   Luo, L ^a   Dwyer, D ^a   Chang, M ^a   Horkko, S ^a   Palinski, W ^a   Stall, A ^a   Witztum, J L ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; B LYMPHOCYTE RECEPTOR; CELL SURFACE RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; LOW DENSITY LIPOPROTEIN RECEPTOR; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY SPECIFICITY; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; B LYMPHOCYTE; CONFERENCE PAPER; IMMUNE RESPONSE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALIA; MAMMALIA;

EID: 0033767120     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-57284-5_20     Document Type: Conference Paper

References (49)

1. B-1 cells and their reactivity with the murine intestinal microflora
2. Antiphosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae
3. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection
4. Control of early viral and bacterial distribution and disease by natural antibodies
5. A developmental switch in B lymphopoiesis
6. B-cell lineages exist in the mouse
7. B-cell activation by cross-linking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes
8. Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: Two B-cell activation pathways
9. B-1 cells are made, not born
10. B-1 cell development: Evidence for an uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation
11. Peritoneal Ly-1 B cells: Genetic control, autoantibody production, increased lambda light chain expression
12. Signal transducer and activator of transcription-3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes
13. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice
14. The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation
15. Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81
16. Impaired B cell maturation in mice lacking Bruton's tyrosine kinase (Btk) and CD40
17. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene
18. Hyperresponsive B cells in CD22-deficient mice
19. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection
20. Production of immunoglobulin isotypes by Ly-1+ B cells in viable motheaten and normal mice
21. Hyperresponsive B cells in CD22-deficient mice
22. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19
23. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene
24. Antigen receptor signaling gives lymphocytes a long life
25. Aberrant B cell development and immune response in mice with a compromised BCR complex
26. Lipoproteins, lipoporatein oxidation and atherogenesis
27. Reduction of atherosclerosis in mice by inhibition of CD40 signalling
28. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes
29. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma
30. Low density lipoprotein undergoes oxidative modification in vivo
31. Autoantibodies to OxLDL are decreased in individuals with borderline hypertension
32. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: Evidence that oxidation-specific epitopes mediate macrophage recognition
33. Natural history of the myeloma
34. Three IgA myeloma immunoglobulins from the BALB/c mouse: Precipitation and pneumococcal C polysaccharide
35. Antigen-binding myeloma proteins of mice
36. Inheritance of an idiotype associated with the immune response of inbred mice to phosphorylcholine
37. Expression of phosphorylcholine-specific B cells during murine development
38. Phosphorylcholine: Friend or foe of the immune system
39. The monoclonal antiphosphorylcholine antibody response in several murine strains: Genetic implications of a diverse repertoire
40. The frequency of phosphorylcholine-specific B cells in conventional and germfree BALB/C mice
41. All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes
42. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins
43. Normal mouse peritoneum contains a large population of Ly-1+ (CD5) B cells that recognize phosphatidyl choline. Relationship to cells that secrete hemolytic antibody specific for autologous erythrocytes
44. Endotoxin shock in antibody-deficient mice: Unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide
45. Intestinal reperfusion injury is mediated by IgM and complement
46. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement
47. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM
48. Positive selection of natural autoreactive B cells
49. Natural autoantibodies to thymocytes: Origin, VH genes, fine specificities, and the role of Thy-1 glycoprotein